Lonza | LONN - Des Atouts





Des Atouts Changement Date
Akzo Nobel EUR 13.95B 55M 2025-12
Alcon AG USD 31.56B 31M 2025-12
Almirall EUR 2.34B 29.21M 2025-12
AstraZeneca USD 114.07B 382M 2025-12
BASF EUR 76.17B 267M 2025-12
Bayer EUR 104.54B 331M 2025-12
Beiersdorf EUR 12.76B 166M 2025-12
Covestro EUR 13.47B 245M 2025-12
Demant DKK 39.07B 6.43B 2025-12
Fresenius EUR 42.46B 1.14B 2025-09
Fresenius Medical Care EUR 31B 115.33M 2025-12
Geberit CHF 3.86B 252.6M 2025-12
Genmab DKK 12.87B 5.85B 2025-12
Givaudan CHF 11.86B 587M 2025-12
GlaxoSmithKline GBP 61.12B 221M 2025-12
GN Store Nord DKK 29.23B 170M 2025-12
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Johnson Matthey GBP 5.83B 362M 2025-12
Merck EUR 51.53B 600M 2025-12
Novartis USD 110.95B 3.66B 2025-12
Philips EUR 26.94B 605M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
Sanofi EUR 126.81B 2.99B 2025-12
Sika AG CHF 15.15B 245M 2025-12
Smith & Nephew USD 10.69B 150M 2025-12
Solvay EUR 6.15B 173M 2025-12
UCB EUR 18.16B 971M 2025-12